210 related articles for article (PubMed ID: 31804525)
1. Prophylactic potential of cytolethal distending toxin B (CdtB) subunit of typhoid toxin against Typhoid fever.
Thakur R; Pathania P; Kaur N; Joshi V; Kondepudi KK; Suri CR; Rishi P
Sci Rep; 2019 Dec; 9(1):18404. PubMed ID: 31804525
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal immunization of recombinant HSP70 (DnaK) of Salmonella Typhi induces a predominant Th2 response and protective immunity in mice against lethal Salmonella infection.
Paliwal PK; Bansal A; Sagi SS; Sairam M
Vaccine; 2011 Sep; 29(38):6532-9. PubMed ID: 21767594
[TBL] [Abstract][Full Text] [Related]
3. Serodiagnostic evaluation of recombinant CdtB of S. Typhi as a potential candidate for acute typhoid.
Sharma T; Sharma C; Sankhyan A; Bedi SP; Bhatnagar S; Khanna N; Gautam V; Sethi S; Vrati S; Tiwari A
Immunol Res; 2018 Aug; 66(4):503-512. PubMed ID: 29931558
[TBL] [Abstract][Full Text] [Related]
4. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
5. Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.
Wetter M; Kowarik M; Steffen M; Carranza P; Corradin G; Wacker M
Glycoconj J; 2013 Jul; 30(5):511-22. PubMed ID: 23053636
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620
[TBL] [Abstract][Full Text] [Related]
7. Development of a synthetic Vi polysaccharide vaccine for typhoid fever.
Ni Y; Springer MJ; Guo J; Finger-Baker I; Wilson JP; Cobb RR; Turner D; Tizard I
Vaccine; 2017 Dec; 35(51):7121-7126. PubMed ID: 29150208
[TBL] [Abstract][Full Text] [Related]
8. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
[TBL] [Abstract][Full Text] [Related]
9. Dual immunization with CdtB protein and flagellin epitope offers augmented protection against enteric fever in mice.
Vij S; Thakur R; Singh RP; Kumar R; Pathania P; Gupta V; Suri CR; Rishi P
Life Sci; 2023 Dec; 334():122216. PubMed ID: 37918629
[TBL] [Abstract][Full Text] [Related]
10. Characterization of an outer membrane protein of Salmonella enterica serovar typhimurium that confers protection against typhoid.
Hamid N; Jain SK
Clin Vaccine Immunol; 2008 Sep; 15(9):1461-71. PubMed ID: 18650399
[TBL] [Abstract][Full Text] [Related]
11. Serum bactericidal assay for the evaluation of typhoid vaccine using a semi-automated colony-counting method.
Jang MS; Sahastrabuddhe S; Yun CH; Han SH; Yang JS
Microb Pathog; 2016 Aug; 97():19-26. PubMed ID: 27216239
[TBL] [Abstract][Full Text] [Related]
12. Contribution of typhoid toxin in the pathogenesis of Salmonella Typhi.
Thakur R; Suri CR; Rishi P
Microb Pathog; 2022 Mar; 164():105444. PubMed ID: 35149176
[TBL] [Abstract][Full Text] [Related]
13. Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a.
Darton TC; Jones C; Blohmke CJ; Waddington CS; Zhou L; Peters A; Haworth K; Sie R; Green CA; Jeppesen CA; Moore M; Thompson BA; John T; Kingsley RA; Yu LM; Voysey M; Hindle Z; Lockhart S; Sztein MB; Dougan G; Angus B; Levine MM; Pollard AJ
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004926. PubMed ID: 27533046
[TBL] [Abstract][Full Text] [Related]
14. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
Kothari N; Kothari S; Choi YJ; Dey A; Briles DE; Rhee DK; Carbis R
Vaccine; 2015 Feb; 33(6):783-8. PubMed ID: 25545593
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of purified Vi polysaccharide typhoid vaccine.
Park JH; Hong JJ; Choi ES; Lee JW; Park JH
J Vet Sci; 2002 Jun; 3(2):67-70. PubMed ID: 12441674
[TBL] [Abstract][Full Text] [Related]
16. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
[TBL] [Abstract][Full Text] [Related]
18. Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
Hart PJ; O'Shaughnessy CM; Siggins MK; Bobat S; Kingsley RA; Goulding DA; Crump JA; Reyburn H; Micoli F; Dougan G; Cunningham AF; MacLennan CA
PLoS One; 2016; 11(1):e0145945. PubMed ID: 26741681
[TBL] [Abstract][Full Text] [Related]
19. Evolution of host adaptation in the Salmonella typhoid toxin.
Gao X; Deng L; Stack G; Yu H; Chen X; Naito-Matsui Y; Varki A; Galán JE
Nat Microbiol; 2017 Dec; 2(12):1592-1599. PubMed ID: 28993610
[TBL] [Abstract][Full Text] [Related]
20. Transcutaneous Vaccination with Conjugate Typhoid Vaccine Vi-DT Induces Systemic, Mucosal, and Memory Anti-Polysaccharide Responses.
Bhuiyan MS; Kalsy A; Arifuzzaman M; Charles RC; Harris JB; Calderwood SB; Qadri F; Ryan ET
Am J Trop Med Hyg; 2020 Sep; 103(3):1032-1038. PubMed ID: 32720632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
